FINISHED DOSAGE FORMULATIONS
Drug : GABAPENTIN
Dosage Form : TABLET; ORAL
Application Number : 203244
Country : US
Patented : No
Drug : FAMCICLOVIR
Dosage Form : TABLET; ORAL
Application Number : 91480
Country : US
Patented : No

Drug : FENOFIBRATE
Dosage Form : TABLET; ORAL
Application Number : 205118
Country : US
Patented : No

Drug : LOTEMAX SM
Dosage Form : GEL; OPHTHALMIC
Application Number : 208219
Country : US
Patented : Yes

PREDNISOLONE SODIUM PHOSPHATE; SULFACETAMIDE SODIUM
Drug : SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE
Dosage Form : SOLUTION/DROPS; OPHTHALMIC
Application Number : 74449
Country : US
Patented : No

Drug : CHILDRENS ALLEGRA HIVES
Dosage Form : TABLET; ORAL
Application Number : 20872
Country : US
Patented : No

Drug : ALLEGRA ALLERGY
Dosage Form : TABLET; ORAL
Application Number : 20872
Country : US
Patented : No

Drug : CHILDRENS ALLEGRA HIVES
Dosage Form : SUSPENSION; ORAL
Application Number : 201373
Country : US
Patented : Yes

Drug : CHILDRENS ALLEGRA ALLERGY
Dosage Form : TABLET; ORAL
Application Number : 20872
Country : US
Patented : No

Drug : CHILDRENS ALLEGRA ALLERGY
Dosage Form : SUSPENSION; ORAL
Application Number : 201373
Country : US
Patented : Yes

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]POLOXAMER 407
Route : INTRATYMPANIC
CAS : 691397-13-4
UNII : TUF2IVW3M2
Potency Amount : 15.1
Potency Unit : %W/W

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLOXAMER 407
Route : OPHTHALMIC
CAS : 691397-13-4
UNII : TUF2IVW3M2
Potency Amount : 0.2
Potency Unit : %

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLOXAMER 407
Route : OPHTHALMIC
CAS : 691397-13-4
UNII : TUF2IVW3M2
Potency Amount : 0.1
Potency Unit : %

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLOXAMER 407
Route : ORAL
CAS : 691397-13-4
UNII : TUF2IVW3M2
Potency Amount : 0.9
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLOXAMER 407
Route : ORAL
CAS : 691397-13-4
UNII : TUF2IVW3M2
Potency Amount : 1
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLOXAMER 407
Route : ORAL
CAS : 691397-13-4
UNII : TUF2IVW3M2
Potency Amount : 40
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLOXAMER 407
Route : ORAL
CAS : 691397-13-4
UNII : TUF2IVW3M2
Potency Amount : 5
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLOXAMER 407
Route : ORAL
CAS : 691397-13-4
UNII : TUF2IVW3M2
Potency Amount : 5
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLOXAMER 407
Route : ORAL
CAS : 691397-13-4
UNII : TUF2IVW3M2
Potency Amount : 126
Potency Unit : MG/25.169GM

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLOXAMER 407
Route : ORAL
CAS : 691397-13-4
UNII : TUF2IVW3M2
Potency Amount : 50
Potency Unit : MG/5ML

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
EXCIPIENTS BY APPLICATIONS
MARKET PLACE